Overview

Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the late asthmatic response, safety and tolerability of AMG 157 following multiple intravenous (IV) dose administration in subjects with mild atopic asthma.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen